Search
Patexia Research
Case number 2022-1307

Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Limited > Documents

Date Field Doc. No.Description (Pages)
Jan 11, 2022 5 ORDER consolidating appeals (22-1258, 22-1307). Appellants' opening briefs are due no later than February 28, 2022. Service as of this date by the Clerk of Court. [823946] [22-1258, 22-1307] [JCW] [Entered: 01/11/2022 04:30 PM] (2)
Jan 11, 2022 6 Note to File: The following cases are consolidated: 22-1258 Lead with 22-1307 Member Case. The parties must file all documents in the lead appeal only. [823949] [22-1258, 22-1307] [JCW] [Entered: 01/11/2022 04:31 PM] (0)
Jan 10, 2022 2 Entry of appearance for Barbara L. Mullin; Andrew D. Cohen as counsel for Appellees Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.. Service: 01/10/2022 by email. [823572] [22-1307] [Barbara Mullin] [Entered: 01/10/2022 03:03 PM] (2)
Jan 10, 2022 3 Docketing Statement for the Appellees Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.. Service: 01/10/2022 by email. [823576] [22-1307] [Barbara Mullin] [Entered: 01/10/2022 03:06 PM] (2)
Jan 10, 2022 4 Certificate of Interest for Appellees Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.. Service: 01/10/2022 by email. [823578] [22-1307] [Barbara Mullin] [Entered: 01/10/2022 03:08 PM] (3)
Dec 28, 2021 1 Appeal docketed. Received: 12/27/2021. [821502]Entry of Appearance is due on 01/11/2022. Certificate of Interest is due on 01/11/2022. Docketing Statement is due on 01/11/2022. Appellant's brief is due on 02/28/2022. [EKD] [Entered: 12/28/2021 11:10 AM] (17)
Menu